Biochemical outcome in metastatic prostate cancer patients following prostate-directed radiotherapy
CONCLUSION: Prostate-directed RT improved BPFS and OS in mPCa patients, particularly in those with low volume and hormonal-sensitive disease.TRIAL REGISTRATION: This trial is registered on (27/4/2023), retrospectively registered with pactr.samrc.ac.za, PACTR202305854600529, URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25510.PMID:38566761 | PMC:PMC10984844 | DOI:10.3332/ecancer.2024.1686
Source: Ecancermedicalscience - Category: Cancer & Oncology Authors: Heba Maged Ayoub Fifi Mostafa Elsayed Maha Lotfy Zamzam Ihab Mohamed Hassanin Eman Essam Elsemary Source Type: research